Cephea South America Feasibility Study — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Cephea South America Feasibility Study — Stella

Home/Mitral Regurgitation/

View on ClinicalTrials.gov

Recruiting

Back to Mitral Regurgitation trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(3 sites)

Brazil

Instituto do Coracao (InCor) - HCFMUSP, São Paulo

Chile

Instituto Nacional del Torax, Santiago

Hospital Clinico San Borja Arriarán, Santiago

Key details

Sponsor

Abbott Medical Devices

Enrollment target

~20 participants

Started

June 2025

Primary completion

September 2026

Age range

18 Years and older

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.